SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Strategies & Market Trends : Fidelity Select Sector funds -- Ignore unavailable to you. Want to Upgrade?


To: Julius Wong who wrote (2380)3/7/2000 12:14:00 AM
From: Julius Wong  Read Replies (2) | Respond to of 4916
 
Battelle's list of the top 10 strategic technologies for 2020:

1. Genetic-based Medical and Health Care. Over the next 20 years, we will witness an explosion of medical technology originating from genetic research, giving us the ability to detect and correct many genetic-based diseases before they arise-possibly even in the womb.

A wide range of new pharmaceuticals that originated from genetic research will come onto the market in the next 20 years, leading to treatments, cures, and preventive measures for a host of ailments. They may range from treatments for life-threatening diseases to psychological disorders to cosmetic problems.

Most incredible, some of these treatments will be personalized to meet the unique needs of an individual's genetic makeup.

"Your doctor might have a record of your genetic makeup," says Eric Majewski of Medical Products, "and he or she might be able to prescribe medications, diets, or other treatments to fit your own particular needs. It will really be the ultimate in individualized care."

Battelle forecasters say genetic research also will lead to cloned human organs within 20 years. These organs will be grown and used in transplants.

... ... ...

Battelle, headquartered in Columbus, Ohio, focuses on technology development and commercialization and product development. With 7,500 employees at more than 60 locations, Battelle develops technologies and products for industry and government. Annual revenues are approximately $1 billion.